Literature DB >> 21252020

Abortion of myocardial infarction by primary angioplasty mainly depends on preprocedural TIMI flow.

Ralf Birkemeyer1, Andreas Rillig, Fabian Treusch, Annette Koch, Tomislav Miljak, Udo Meyerfeldt, Markus Kunze, Werner Jung, Martin Höher.   

Abstract

AIMS: To define frequency and predictors of aborted myocardial infarctions (MI) after primary angioplasty. METHODS AND
RESULTS: We analysed 196 consecutive patients with the clinical diagnosis of ST-elevation acute coronary syndrome (ST-ACS) admitted for primary angioplasty to one interventional facility between October 2005 and September 2006. Aborted MI was defined as a creatine increase of less than two times the upper limit of normal, combined with typical evolutionary electrocardiographic changes. Masquerading MI was diagnosed if evolutionary changes were missing or could be attributed to other causes. Thirty-four patients (17,3%) had an aborted and nine (4,6%) a masquerading MI. The main predictor of abortion was Thrombolysis In Myocardial Infarction (TIMI) flow 2 or 3 prior to procedure. The in-hospital mortality of aborted MI was 0%, the one year mortality 2.9%. Sixteen patients without prior or inter-current myocardial infarction had a preserved ejection fraction on cardiac MR at 12 months; in six patients even without any detection of late enhancement.
CONCLUSIONS: There is a substantial proportion of aborted myocardial infarction after primary angioplasty, corresponding to a small or even non detectable scar formation in terms of late enhancement on cardiac MR. Preprocedural TIMI flow 2 or 3 is the main predictor of aborted MI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252020     DOI: 10.4244/EIJV6I7A146

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  2 in total

Review 1.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

2.  Short term cost effectiveness of a regional myocardial infarction network.

Authors:  Ralf Birkemeyer; Anke Dauch; Alfred Müller; Manfred Beck; Henrik Schneider; Hueseyin Ince; Werner Jung; Steffen Wahler
Journal:  Health Econ Rev       Date:  2013-04-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.